Preferred Label : PCWG Scher Prostate Cancer 2016 Oncology Response Criteria;
NCIt related terms : PCWG3; PCWG SCHER PROSTATE CANCER 2016;
Alternative definition : CDISC: Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated
Recommendations From the Prostate Cancer Clinical Trials Working Group 3. (Scher HI,
Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci
MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly
WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor
O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH,
Halabi S, Kantoff PW, Armstrong AJ. Trial Design and Objectives for Castration-Resistant
Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials
Working Group 3. J Clin Oncol. 2016 Apr 20;34(12):1402-18.);
NCI Metathesaurus CUI : CL521127;
Origin ID : C132454;
UMLS CUI : C4330913;
Semantic type(s)
- concept_is_in_subset
